The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5...

Description complète

Détails bibliographiques
Auteurs principaux:	Rodríguez Cruz, P, Palace, J, Beeson, D
Format:	Journal article
Langue:	English
Publié:	MDPI 2018

Documents similaires

Congenital myasthenic syndromes and the neuromuscular junction.
par: Cruz, P, et autres
Publié: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
par: Beeson, D, et autres
Publié: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
par: Beeson, D, et autres
Publié: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
par: Beeson, D
Publié: (2008)

The congenital myasthenic syndromes.
par: Palace, J, et autres
Publié: (2008)

Congenital myasthenic syndromes.
par: Beeson, D, et autres
Publié: (1997)

Congenital myasthenic syndromes: an update.
par: Finlayson, S, et autres
Publié: (2013)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
par: Xufeng Liao, et autres
Publié: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
par: Cossins, J, et autres
Publié: (2012)

Therapeutic strategies for congenital myasthenic syndromes
par: Lee, M, et autres
Publié: (2018)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
par: Healy, E, et autres
Publié: (2014)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
par: Lashley, D, et autres
Publié: (2009)

Inherited disorders of the neuromuscular junction: an update.
par: Rodríguez Cruz, P, et autres
Publié: (2014)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
par: Man, S, et autres
Publié: (2005)

Synaptic dysfunction in congenital myasthenic syndromes.
par: Beeson, D
Publié: (2012)

Congenital myasthenic syndromes: recent advances
par: Beeson, D
Publié: (2016)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
par: Lashley, D, et autres
Publié: (2010)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
par: Burke, G, et autres
Publié: (2006)

DOK7 congenital myasthenic syndrome.
par: Palace, J
Publié: (2012)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
par: Vincent, A, et autres
Publié: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
par: Vincent, A, et autres
Publié: (1993)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
par: Finlayson, S, et autres
Publié: (2016)

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes
par: Webster, R
Publié: (2018)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
par: Vanhaesebrouck, A
Publié: (2018)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
par: Finlayson, S, et autres
Publié: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
par: Finlayson, S, et autres
Publié: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
par: Finlayson, S, et autres
Publié: (2013)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
par: Kinali, M, et autres
Publié: (2008)

Congenital myasthenic syndrome caused by mutations in DPAGT.
par: Klein, A, et autres
Publié: (2015)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
par: Chaouch, A, et autres
Publié: (2012)

Congenital myasthenic syndromes: Report of 7 Chile
par: Kleinsteuber, K, et autres
Publié: (2003)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
par: Spillane, J, et autres
Publié: (2012)

Congenital Myasthenic Syndromes
par: J Gordon Millichap
Publié: (1994-01-01)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
par: Belaya, K, et autres
Publié: (2012)

Therapy of myasthenic syndrome
par: Palace, J
Publié: (2012)

Congenital myasthenic syndromes
par: Josef Finsterer
Publié: (2019-02-01)

Congenital Myasthenic Syndrome
par: WANG Wenqing, et autres
Publié: (2022-04-01)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
par: Rodríguez Cruz, PM, et autres
Publié: (2019)

New diagnosis in Chilean population: congenital myasthenic syndromes
par: Kleinsteuber, K, et autres
Publié: (2005)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
par: Yamanashi, Y, et autres
Publié: (2008)